ZPAB 📈 Lyxor Net Zero 2050 S&P - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2195226068 • Eurozone Large-Cap Equity

ZPAB: Stocks, Bonds, Futures, Options, Commodities

‣ Company URL: https://first-eagle.amundi.com/ ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Dev Ezn TME NR EUR

Additional Sources for ZPAB ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ZPAB ETF Overview

Market Cap in USD 1,901m
Category Eurozone Large-Cap Equity
TER 0.20%
IPO / Inception 2020-07-06

ZPAB ETF Ratings

Growth 5y 63.7%
Fundamental -
Dividend -
Rel. Strength Industry 199
Analysts -
Fair Price Momentum 30.64 EUR
Fair Price DCF -

ZPAB Dividends

No Dividends Paid

ZPAB Growth Ratios

Growth Correlation 3m -18.1%
Growth Correlation 12m 79.1%
Growth Correlation 5y 73%
CAGR 5y 10.14%
CAGR/Mean DD 5y 1.49
Sharpe Ratio 12m 0.74
Alpha -5.84
Beta 0.70
Volatility 10.09%
Current Volume 6.9k
Average Volume 20d 3.4k
What is the price of ZPAB stocks?
As of December 22, 2024, the stock is trading at EUR 31.50 with a total of 6,946 shares traded.
Over the past week, the price has changed by -1.70%, over one month by +2.96%, over three months by -0.27% and over the past year by +13.14%.
Is Lyxor Net Zero 2050 S&P a good stock to buy?
Yes. Based on ValueRay Analyses, Lyxor Net Zero 2050 S&P (XETRA:ZPAB) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 63.70 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZPAB as of December 2024 is 30.64. This means that ZPAB is currently overvalued and has a potential downside of -2.73%.
Is ZPAB a buy, sell or hold?
Lyxor Net Zero 2050 S&P has no consensus analysts rating.
What are the forecast for ZPAB stock price target?
According to ValueRays Forecast Model, ZPAB Lyxor Net Zero 2050 S&P will be worth about 33.8 in December 2025. The stock is currently trading at 31.50. This means that the stock has a potential upside of +7.17%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 33.8 7.2%